Teachers Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-92,400
| Closed | -$1.03M | – | 3113 |
|
|
2017
Q3 | $1.03M | Hold |
92,400
| – | – | ﹤0.01% | 2217 |
|
|
2017
Q2 | $1.02M | Buy |
92,400
+2,577
| +3% | +$25.8K | ﹤0.01% | 2224 |
|
|
2017
Q1 | $880K | Buy |
89,823
+9,340
| +12% | +$93.3K | ﹤0.01% | 2259 |
|
|
2016
Q4 | $869K | Buy |
80,483
+2,370
| +3% | +$23.7K | ﹤0.01% | 2253 |
|
|
2016
Q3 | $801K | Hold |
78,113
| – | – | ﹤0.01% | 2214 |
|
|
2016
Q2 | $1.02M | Buy |
78,113
+4,392
| +6% | +$57.5K | ﹤0.01% | 2025 |
|
|
2016
Q1 | $811K | Hold |
73,721
| – | – | ﹤0.01% | 2082 |
|
|
2015
Q4 | $678K | Hold |
73,721
| – | – | ﹤0.01% | 2236 |
|
|
2015
Q3 | $512K | Hold |
73,721
| – | – | ﹤0.01% | 2382 |
|
|
2015
Q2 | $724K | Sell |
73,721
-3,056
| -4% | -$27.8K | ﹤0.01% | 2305 |
|
|
2015
Q1 | $680K | Hold |
76,777
| – | – | ﹤0.01% | 2257 |
|
|
2014
Q4 | $673K | Hold |
76,777
| – | – | ﹤0.01% | 2261 |
|
|
2014
Q3 | $529K | Hold |
76,777
| – | – | ﹤0.01% | 2370 |
|
|
2014
Q2 | $404K | Sell |
76,777
-1,028
| -1% | -$5K | ﹤0.01% | 2557 |
|
|
2014
Q1 | $354K | Hold |
77,805
| – | – | ﹤0.01% | 2584 |
|
|
2013
Q4 | $392K | Hold |
77,805
| – | – | ﹤0.01% | 2523 |
|
|
2013
Q3 | $394K | Buy |
77,805
+4,475
| +6% | +$24.9K | ﹤0.01% | 2465 |
|
|
2013
Q2 | $364K | Buy |
+73,330
| New | +$349K | ﹤0.01% | 2420 |
|
Teachers Advisors's SCLN Position: Q4 2017 in Review
Teachers Advisors sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 92,400 shares — an estimated $1.03M sold.
Teachers Advisors first reported a position in SCLN in Q2 2013 and held it in 18 quarters. The position peaked at $1.03M in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.
- Teachers Advisors reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
- Teachers Advisors sold 92,400 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $1.03M.
- Teachers Advisors first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 18 quarters.
- Teachers Advisors's Sciclone Pharmaceuticals Inc position peaked at $1.03M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.
Based on Teachers Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.